0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Photodynamic Therapy Drugs (PTD) Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-14I17192
Home | Market Reports | Health| Nursing
Global Photodynamic Therapy Drugs PTD Market Research Report 2024
BUY CHAPTERS

Global Photodynamic Therapy Drugs (PTD) Market Research Report 2026

Code: QYRE-Auto-14I17192
Report
2026-04-10
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Photodynamic Therapy Drugs (PTD) Market

The global Photodynamic Therapy Drugs (PTD) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic therapy, a non-invasive medical treatment that involves the administration of light-sensitive drugs followed by exposure to specific wavelengths of light to target and destroy abnormal cells, such as cancer cells or skin lesions.
The North American market for Photodynamic Therapy Drugs (PTD) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Photodynamic Therapy Drugs (PTD) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Photodynamic Therapy Drugs (PTD) in Pancreatic Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Photodynamic Therapy Drugs (PTD) include DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Photodynamic Therapy Drugs (PTD) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Photodynamic Therapy Drugs (PTD). The Photodynamic Therapy Drugs (PTD) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Photodynamic Therapy Drugs (PTD) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Photodynamic Therapy Drugs (PTD) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Photodynamic Therapy Drugs (PTD) Market Report

Report Metric Details
Report Name Photodynamic Therapy Drugs (PTD) Market
Segment by Type
  • Aminolevulinic Acid
  • Hemoporfin
  • Sinoporphyrin Sodium
  • Others
Segment by Application
  • Pancreatic Cancer
  • Esophageal Cancer
  • Skin Cancer
  • Lung Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, APExBIO Technology, Thermo Fisher
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Photodynamic Therapy Drugs (PTD) companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Photodynamic Therapy Drugs (PTD) Market report?

Ans: The main players in the Photodynamic Therapy Drugs (PTD) Market are DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, APExBIO Technology, Thermo Fisher

What are the Application segmentation covered in the Photodynamic Therapy Drugs (PTD) Market report?

Ans: The Applications covered in the Photodynamic Therapy Drugs (PTD) Market report are Pancreatic Cancer, Esophageal Cancer, Skin Cancer, Lung Cancer, Others

What are the Type segmentation covered in the Photodynamic Therapy Drugs (PTD) Market report?

Ans: The Types covered in the Photodynamic Therapy Drugs (PTD) Market report are Aminolevulinic Acid, Hemoporfin, Sinoporphyrin Sodium, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Aminolevulinic Acid
1.2.3 Hemoporfin
1.2.4 Sinoporphyrin Sodium
1.2.5 Others
1.3 Market by Application
1.3.1 Global Photodynamic Therapy Drugs (PTD) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pancreatic Cancer
1.3.3 Esophageal Cancer
1.3.4 Skin Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Photodynamic Therapy Drugs (PTD) Market Perspective (2021–2032)
2.2 Global Photodynamic Therapy Drugs (PTD) Growth Trends by Region
2.2.1 Global Photodynamic Therapy Drugs (PTD) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Photodynamic Therapy Drugs (PTD) Historic Market Size by Region (2021–2026)
2.2.3 Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Region (2027–2032)
2.3 Photodynamic Therapy Drugs (PTD) Market Dynamics
2.3.1 Photodynamic Therapy Drugs (PTD) Industry Trends
2.3.2 Photodynamic Therapy Drugs (PTD) Market Drivers
2.3.3 Photodynamic Therapy Drugs (PTD) Market Challenges
2.3.4 Photodynamic Therapy Drugs (PTD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Photodynamic Therapy Drugs (PTD) Players by Revenue
3.1.1 Global Top Photodynamic Therapy Drugs (PTD) Players by Revenue (2021–2026)
3.1.2 Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Players (2021–2026)
3.2 Global Top Photodynamic Therapy Drugs (PTD) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Photodynamic Therapy Drugs (PTD) Revenue
3.4 Global Photodynamic Therapy Drugs (PTD) Market Concentration Ratio
3.4.1 Global Photodynamic Therapy Drugs (PTD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Photodynamic Therapy Drugs (PTD) Revenue in 2025
3.5 Global Key Players of Photodynamic Therapy Drugs (PTD) Head Offices and Areas Served
3.6 Global Key Players of Photodynamic Therapy Drugs (PTD), Products and Applications
3.7 Global Key Players of Photodynamic Therapy Drugs (PTD), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Photodynamic Therapy Drugs (PTD) Breakdown Data by Type
4.1 Global Photodynamic Therapy Drugs (PTD) Historic Market Size by Type (2021–2026)
4.2 Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Type (2027–2032)
5 Photodynamic Therapy Drugs (PTD) Breakdown Data by Application
5.1 Global Photodynamic Therapy Drugs (PTD) Historic Market Size by Application (2021–2026)
5.2 Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
6.2 North America Photodynamic Therapy Drugs (PTD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Photodynamic Therapy Drugs (PTD) Market Size by Country (2021–2026)
6.4 North America Photodynamic Therapy Drugs (PTD) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
7.2 Europe Photodynamic Therapy Drugs (PTD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (2021–2026)
7.4 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
8.2 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region (2021–2026)
8.4 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
9.2 Latin America Photodynamic Therapy Drugs (PTD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Photodynamic Therapy Drugs (PTD) Market Size by Country (2021–2026)
9.4 Latin America Photodynamic Therapy Drugs (PTD) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
10.2 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country (2021–2026)
10.4 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DUSA Pharmaceuticals
11.1.1 DUSA Pharmaceuticals Company Details
11.1.2 DUSA Pharmaceuticals Business Overview
11.1.3 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Introduction
11.1.4 DUSA Pharmaceuticals Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.1.5 DUSA Pharmaceuticals Recent Development
11.2 Soligenix
11.2.1 Soligenix Company Details
11.2.2 Soligenix Business Overview
11.2.3 Soligenix Photodynamic Therapy Drugs (PTD) Introduction
11.2.4 Soligenix Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.2.5 Soligenix Recent Development
11.3 ORALIA
11.3.1 ORALIA Company Details
11.3.2 ORALIA Business Overview
11.3.3 ORALIA Photodynamic Therapy Drugs (PTD) Introduction
11.3.4 ORALIA Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.3.5 ORALIA Recent Development
11.4 Theralase
11.4.1 Theralase Company Details
11.4.2 Theralase Business Overview
11.4.3 Theralase Photodynamic Therapy Drugs (PTD) Introduction
11.4.4 Theralase Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.4.5 Theralase Recent Development
11.5 Quest Pharmatech
11.5.1 Quest Pharmatech Company Details
11.5.2 Quest Pharmatech Business Overview
11.5.3 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Introduction
11.5.4 Quest Pharmatech Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.5.5 Quest Pharmatech Recent Development
11.6 Biofrontera
11.6.1 Biofrontera Company Details
11.6.2 Biofrontera Business Overview
11.6.3 Biofrontera Photodynamic Therapy Drugs (PTD) Introduction
11.6.4 Biofrontera Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.6.5 Biofrontera Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Photodynamic Therapy Drugs (PTD) Introduction
11.7.4 Merck Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.7.5 Merck Recent Development
11.8 QIYUE BIOLOGY
11.8.1 QIYUE BIOLOGY Company Details
11.8.2 QIYUE BIOLOGY Business Overview
11.8.3 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Introduction
11.8.4 QIYUE BIOLOGY Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.8.5 QIYUE BIOLOGY Recent Development
11.9 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
11.9.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Details
11.9.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Business Overview
11.9.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Introduction
11.9.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.9.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Development
11.10 Shanghai Guangsheng Pharmaceutical
11.10.1 Shanghai Guangsheng Pharmaceutical Company Details
11.10.2 Shanghai Guangsheng Pharmaceutical Business Overview
11.10.3 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Introduction
11.10.4 Shanghai Guangsheng Pharmaceutical Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.10.5 Shanghai Guangsheng Pharmaceutical Recent Development
11.11 APExBIO Technology
11.11.1 APExBIO Technology Company Details
11.11.2 APExBIO Technology Business Overview
11.11.3 APExBIO Technology Photodynamic Therapy Drugs (PTD) Introduction
11.11.4 APExBIO Technology Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.11.5 APExBIO Technology Recent Development
11.12 Thermo Fisher
11.12.1 Thermo Fisher Company Details
11.12.2 Thermo Fisher Business Overview
11.12.3 Thermo Fisher Photodynamic Therapy Drugs (PTD) Introduction
11.12.4 Thermo Fisher Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.12.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Aminolevulinic Acid
 Table 3. Key Players of Hemoporfin
 Table 4. Key Players of Sinoporphyrin Sodium
 Table 5. Key Players of Others
 Table 6. Global Photodynamic Therapy Drugs (PTD) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Photodynamic Therapy Drugs (PTD) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Photodynamic Therapy Drugs (PTD) Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Photodynamic Therapy Drugs (PTD) Market Share by Region (2021–2026)
 Table 10. Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Photodynamic Therapy Drugs (PTD) Market Share by Region (2027–2032)
 Table 12. Photodynamic Therapy Drugs (PTD) Market Trends
 Table 13. Photodynamic Therapy Drugs (PTD) Market Drivers
 Table 14. Photodynamic Therapy Drugs (PTD) Market Challenges
 Table 15. Photodynamic Therapy Drugs (PTD) Market Restraints
 Table 16. Global Photodynamic Therapy Drugs (PTD) Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Photodynamic Therapy Drugs (PTD) Market Share by Players (2021–2026)
 Table 18. Global Top Photodynamic Therapy Drugs (PTD) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Photodynamic Therapy Drugs (PTD) Revenue, 2025
 Table 19. Ranking of Global Top Photodynamic Therapy Drugs (PTD) Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Photodynamic Therapy Drugs (PTD) Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Photodynamic Therapy Drugs (PTD), Headquarters and Area Served
 Table 22. Global Key Players of Photodynamic Therapy Drugs (PTD), Products and Applications
 Table 23. Global Key Players of Photodynamic Therapy Drugs (PTD), Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Photodynamic Therapy Drugs (PTD) Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Type (2021–2026)
 Table 27. Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Type (2027–2032)
 Table 29. Global Photodynamic Therapy Drugs (PTD) Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Application (2021–2026)
 Table 31. Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Application (2027–2032)
 Table 33. North America Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2027–2032
 Table 48. DUSA Pharmaceuticals Company Details
 Table 49. DUSA Pharmaceuticals Business Overview
 Table 50. DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product
 Table 51. DUSA Pharmaceuticals Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 52. DUSA Pharmaceuticals Recent Development
 Table 53. Soligenix Company Details
 Table 54. Soligenix Business Overview
 Table 55. Soligenix Photodynamic Therapy Drugs (PTD) Product
 Table 56. Soligenix Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 57. Soligenix Recent Development
 Table 58. ORALIA Company Details
 Table 59. ORALIA Business Overview
 Table 60. ORALIA Photodynamic Therapy Drugs (PTD) Product
 Table 61. ORALIA Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 62. ORALIA Recent Development
 Table 63. Theralase Company Details
 Table 64. Theralase Business Overview
 Table 65. Theralase Photodynamic Therapy Drugs (PTD) Product
 Table 66. Theralase Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 67. Theralase Recent Development
 Table 68. Quest Pharmatech Company Details
 Table 69. Quest Pharmatech Business Overview
 Table 70. Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product
 Table 71. Quest Pharmatech Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 72. Quest Pharmatech Recent Development
 Table 73. Biofrontera Company Details
 Table 74. Biofrontera Business Overview
 Table 75. Biofrontera Photodynamic Therapy Drugs (PTD) Product
 Table 76. Biofrontera Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 77. Biofrontera Recent Development
 Table 78. Merck Company Details
 Table 79. Merck Business Overview
 Table 80. Merck Photodynamic Therapy Drugs (PTD) Product
 Table 81. Merck Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 82. Merck Recent Development
 Table 83. QIYUE BIOLOGY Company Details
 Table 84. QIYUE BIOLOGY Business Overview
 Table 85. QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product
 Table 86. QIYUE BIOLOGY Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 87. QIYUE BIOLOGY Recent Development
 Table 88. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Details
 Table 89. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Business Overview
 Table 90. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product
 Table 91. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 92. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Development
 Table 93. Shanghai Guangsheng Pharmaceutical Company Details
 Table 94. Shanghai Guangsheng Pharmaceutical Business Overview
 Table 95. Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product
 Table 96. Shanghai Guangsheng Pharmaceutical Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 97. Shanghai Guangsheng Pharmaceutical Recent Development
 Table 98. APExBIO Technology Company Details
 Table 99. APExBIO Technology Business Overview
 Table 100. APExBIO Technology Photodynamic Therapy Drugs (PTD) Product
 Table 101. APExBIO Technology Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 102. APExBIO Technology Recent Development
 Table 103. Thermo Fisher Company Details
 Table 104. Thermo Fisher Business Overview
 Table 105. Thermo Fisher Photodynamic Therapy Drugs (PTD) Product
 Table 106. Thermo Fisher Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
 Table 107. Thermo Fisher Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Photodynamic Therapy Drugs (PTD) Picture
 Figure 2. Global Photodynamic Therapy Drugs (PTD) Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Photodynamic Therapy Drugs (PTD) Market Share by Type: 2025 vs 2032
 Figure 4. Aminolevulinic Acid Features
 Figure 5. Hemoporfin Features
 Figure 6. Sinoporphyrin Sodium Features
 Figure 7. Others Features
 Figure 8. Global Photodynamic Therapy Drugs (PTD) Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Photodynamic Therapy Drugs (PTD) Market Share by Application: 2025 vs 2032
 Figure 10. Pancreatic Cancer Case Studies
 Figure 11. Esophageal Cancer Case Studies
 Figure 12. Skin Cancer Case Studies
 Figure 13. Lung Cancer Case Studies
 Figure 14. Others Case Studies
 Figure 15. Photodynamic Therapy Drugs (PTD) Report Years Considered
 Figure 16. Global Photodynamic Therapy Drugs (PTD) Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 17. Global Photodynamic Therapy Drugs (PTD) Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Photodynamic Therapy Drugs (PTD) Market Share by Region: 2025 vs 2032
 Figure 19. Global Photodynamic Therapy Drugs (PTD) Market Share by Players in 2025
 Figure 20. Global Photodynamic Therapy Drugs (PTD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 21. The Top 10 and 5 Players Market Share by Photodynamic Therapy Drugs (PTD) Revenue in 2025
 Figure 22. North America Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. North America Photodynamic Therapy Drugs (PTD) Market Share by Country (2021–2032)
 Figure 24. United States Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Canada Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe Photodynamic Therapy Drugs (PTD) Market Share by Country (2021–2032)
 Figure 28. Germany Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. France Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. U.K. Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Italy Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Russia Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Ireland Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Share by Region (2021–2032)
 Figure 36. China Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Japan Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. South Korea Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Southeast Asia Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. India Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Australia & New Zealand Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America Photodynamic Therapy Drugs (PTD) Market Share by Country (2021–2032)
 Figure 44. Mexico Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Brazil Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Share by Country (2021–2032)
 Figure 48. Israel Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. UAE Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. DUSA Pharmaceuticals Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 52. Soligenix Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 53. ORALIA Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 54. Theralase Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 55. Quest Pharmatech Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 56. Biofrontera Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 57. Merck Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 58. QIYUE BIOLOGY Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 59. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 60. Shanghai Guangsheng Pharmaceutical Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 61. APExBIO Technology Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 62. Thermo Fisher Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India